《大行報告》大摩上調貓眼(01896.HK)目標價至13.9元 評級「增持」
摩根士丹利發表報告指,貓眼娛樂(01896.HK)早前宣布與騰訊(00700.HK)、美團-W(03690.HK)就渠道流量費進行定價談判。該行評估認為,對貓眼的財務影響好過預期,因此將2023至24財年的每股盈測分別上調10%。由於這個主要憂慮被移除,重申「增持」評級,目標價由12.6元上調至13.9元,相當於明年預測市盈率15倍,列入電影行業首選股。
該行表示,看好貓眼強勁的基本面、結構性市佔擴張、豐富的電影管線催化劑和具有吸引力的估值,現相當於預測明年市盈率10倍,而同業阿里影業(01060.HK)及A股同業則逾25倍,貓眼在進一步重評下估值有望擴至預測市盈率15倍。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.